A Novel Fully Integrated Mobile Management Solution Using Cell Phone Technology for Heart Failure
NCT ID: NCT02935439
Last Updated: 2016-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2011-02-28
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Technology-Based System for Patient Engagement and Physician-Directed Remote Management of Heart Failure
NCT05647317
Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure
NCT06750549
Use of Telemonitoring to Facilitate Heart Failure Medication Titration
NCT04205513
Mobile Health Monitoring Solution for Heart Failure Patients
NCT02594007
CHF Management Using Telemedicine
NCT00309764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cell-Phone Intervention Arm
A standard cell phone system sent web-browser messages daily to ask about their weight and symptoms of heart failure. Participants received up to 3 daily messages 15 minutes apart at a time of their choosing for 90 days. Participants were given a mobile phone for the 90 day period and a weight scale.
Cell Phone
Participants responded to questions about their heart failure symptoms using a cell phone.
Usual Care
Usual Care participants continued to receive care in the Heart Failure Clinic. All subjects were enrolled in the study for 90 days. Participants were given a weight scale.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cell Phone
Participants responded to questions about their heart failure symptoms using a cell phone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have an anticipated survival ≥ 6 months
* Receive care at the University of Miami or Jackson Healthcare system
* 18 years or older
* Able to communicate in English and/or Spanish
* Able to operate a cell phone, read, understand, and respond to the questions on the cell phone, and are able to use the weight scale.
Exclusion Criteria
* History of end-stage heart failure or heart transplantation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
James and Esther King Biomedical Research Program
OTHER
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stuti Dang MD
Clinical Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuti Dang, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Miami VA Healthcare System
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09KC-01
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
20091057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.